US HB5686 | 2017-2018 | 115th Congress
Status
Spectrum: Slight Partisan Bill (Republican 5-2)
Status: Introduced on May 7 2018 - 25% progression, died in chamber
Action: 2018-06-12 - Placed on the Union Calendar, Calendar No. 575.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 7 2018 - 25% progression, died in chamber
Action: 2018-06-12 - Placed on the Union Calendar, Calendar No. 575.
Text: Latest bill text (Introduced) [PDF]
Summary
Medicare CHOICE Act of 2018 Medicare Clear Health Options in Care for Enrollees Act of 2018 This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).
Title
Medicare CHOICE Act of 2018 Medicare Clear Health Options in Care for Enrollees Act of 2018
Sponsors
Rep. Erik Paulsen [R-MN] | Rep. Ron Kind [D-WI] | Rep. Chris Collins [R-NY] | Rep. Conor Lamb [D-PA] |
Sen. Marsha Blackburn [R-TN] | Rep. Brian Fitzpatrick [R-PA] | Rep. Greg Walden [R-OR] |
History
Date | Chamber | Action |
---|---|---|
2018-06-12 | House | Placed on the Union Calendar, Calendar No. 575. |
2018-06-12 | House | Committee on Ways and Means discharged. |
2018-06-12 | House | Reported by the Committee on Energy and Commerce. H. Rept. 115-741, Part I. |
2018-05-16 | House | Referred to the Subcommittee on Health. |
2018-05-09 | House | Ordered to be Reported by Voice Vote. |
2018-05-09 | House | Committee Consideration and Mark-up Session Held. |
2018-05-07 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2018-05-07 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2018-05-07 | House | Introduced in House |
Same As/Similar To
HB5775 (Related) 2018-06-20 - Received in the Senate and Read twice and referred to the Committee on Finance.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
Subjects
Alternative treatments
Drug trafficking and controlled substances
Health
Health care costs and insurance
Medicare
Prescription drugs
Drug trafficking and controlled substances
Health
Health care costs and insurance
Medicare
Prescription drugs